AXIOS December 19, 2023
Tina Reed

The new highly effective class of anti-obesity drugs has often been talked about as an alternative to bariatric surgery — but medications like Wegovy are increasingly being paired with the procedure.

Why it matters: While surgeons say the drugs can especially help people with severe obesity maintain weight loss after surgery, the combination presents a pricey scenario for insurers already grappling with the cost of the drugs alone.

By the numbers: The number of bariatric surgeries performed in the U.S. increased slightly between 2021 and 2022 after the drugs known as GLP-1 agonists exploded on the market, according to medical claims data from FAIR Health.

  • The number of bariatric surgery patients who were subsequently prescribed a GLP-1 more than...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Medical Devices, Patient / Consumer, Pharma, Pharma / Biotech, Provider
OHSU hospital operating at 100%-plus capacity
Stanford Medicine Children’s Health maintains focus on equity in care
The Rise of Hospice Nurses as Authors, Social Media Influencers
MedPAC estimates $84B in Medicare Advantage overpayments in 2025: 10 notes
Big challenges for health system IT execs in the next 12 months

Share This Article